|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Amortization expense | |||||
| Depreciation expense | |||||
| Deferred income taxes | |||||
| Stock-based compensation expense | |||||
| Non-cash lease expense (benefit) | |||||
| Non-cash interest expense for amortization of debt discount and issuance costs | |||||
| Non-cash interest expense for deferred royalty obligation | |||||
| Net amortization of premiums and discounts on investments | |||||
| Non-cash change in fair value of contingent consideration | |||||
| Ironshore acquisition | |||||
| Total non-cash change in fair value of contingent consideration | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventory | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable | |||||
| Accrued liabilities | |||||
| Accrued rebates, returns and discounts | |||||
| Operating lease assets and liabilities | |||||
| Deferred revenue | |||||
| Net cash provided by operating activities | |||||
| Investing activities | |||||
| Acquisition of Ironshore (net of cash acquired) | |||||
| Ironshore acquisition | |||||
| Total acquisition of Ironshore (net of cash acquired) | |||||
| Purchases of property and equipment | |||||
| Purchases of marketable securities | |||||
| Maturities and sales of marketable securities | |||||
| Net cash used in investing activities | |||||
| Financing activities | |||||
| Proceeds from issuances of common stock from employee stock purchase plans | |||||
| Proceeds from the exercise of stock options | |||||
| Payments made for employee stock tax withholdings | |||||
| Repurchases of common stock | |||||
| Repayment of term loans, including debt extinguishment costs | |||||
| Proceeds from issuance of 2025 Credit Facility, net of debt discount and issuance costs | |||||
| Payments made for deferred purchase price for acquisition | |||||
| Proceeds from term note modification, net of fees paid to lender | |||||
| Proceeds from issuances of 2029 Convertible Notes, net of issuance costs | |||||
| Repurchase of 2026 Convertible Notes, including premium | |||||
| Redemption of 2026 Convertible Notes, including premium and redemption costs | |||||
| Repayment of assumed debt from Ironshore Acquisition | |||||
| Net cash used in financing activities | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of year | |||||
| Cash, cash equivalents and restricted cash at end of year | |||||
| Supplemental disclosure of cash flow information | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes | |||||
| Supplemental disclosure of non-cash activities | |||||
| Acquisition of property and equipment in accounts payable and accrued liabilities | |||||
| Note issuance costs in accounts payable and accrued expenses | |||||
| Excise tax on share repurchases in accrued liabilities | |||||
| Acquisition date fair value of contingent consideration | |||||
| Business combination consideration payable | |||||
| Reconciliation of cash, cash equivalents and restricted cash to the Consolidated Balance Sheets | |||||
| Cash and cash equivalents | |||||
| Restricted cash | |||||
Loading...